Liquid Biopsy Improved for Characterization of Metastatic Tumors
The promise of advanced, minimally invasive techniques, such as liquid biopsy, for diagnosing and tracking cancer progression has pushed researchers to develop accurate, scalable approaches for monitoring cancer DNA from blood samples. Now, investigators at the Broad Institute of MIT and Harvard, Koch Institute at MIT, Dana-Farber Cancer Institute (DFCI), and Massachusetts General Hospital have just released data demonstrating that nearly 90% of a tumor's genetic features can be detected in bloo
Read more »